OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk of hepatocellular carcinoma in hepatitis B and D virus co‐infected patients: A systematic review and meta‐analysis of longitudinal studies
Habiba Kamal, Romina Fornes, Johanna Simin, et al.
Journal of Viral Hepatitis (2021) Vol. 28, Iss. 10, pp. 1431-1442
Open Access | Times Cited: 42
Habiba Kamal, Romina Fornes, Johanna Simin, et al.
Journal of Viral Hepatitis (2021) Vol. 28, Iss. 10, pp. 1431-1442
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
Hepatitis D Virus Infection
Tarik Asselah, Mario Rizzetto
New England Journal of Medicine (2023) Vol. 389, Iss. 1, pp. 58-70
Closed Access | Times Cited: 52
Tarik Asselah, Mario Rizzetto
New England Journal of Medicine (2023) Vol. 389, Iss. 1, pp. 58-70
Closed Access | Times Cited: 52
Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
Tarik Asselah, Vladimir Chulanov, Pietro Lampertico, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 2, pp. 133-143
Closed Access | Times Cited: 23
Tarik Asselah, Vladimir Chulanov, Pietro Lampertico, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 2, pp. 133-143
Closed Access | Times Cited: 23
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 500-500
Open Access | Times Cited: 59
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 500-500
Open Access | Times Cited: 59
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
Devin Razavi‐Shearer, Hannah Child, K. Razavi-Shearer, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 232-242
Open Access | Times Cited: 32
Devin Razavi‐Shearer, Hannah Child, K. Razavi-Shearer, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 232-242
Open Access | Times Cited: 32
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 9
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 9
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis
Mario Capasso, Valentina Cossiga, Maria Guarino, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1505-1505
Open Access | Times Cited: 6
Mario Capasso, Valentina Cossiga, Maria Guarino, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1505-1505
Open Access | Times Cited: 6
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 6
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 6
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
A. Wranke, Benjamin Heidrich, Katja Deterding, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1359-1367
Open Access | Times Cited: 15
A. Wranke, Benjamin Heidrich, Katja Deterding, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1359-1367
Open Access | Times Cited: 15
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 5
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 5
Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients
Verdiana Zulian, Leonidas Salichos, Chiara Taibi, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 280-280
Open Access
Verdiana Zulian, Leonidas Salichos, Chiara Taibi, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 280-280
Open Access
Detection of hepatitis delta virus RNA in cervical swab and seminal plasma of chronic hepatitis delta patients
Saruul Enkhjargal, O. Lhagva-Ochir, Altangerel Purvee, et al.
Sexually Transmitted Infections (2025), pp. sextrans-056364
Closed Access
Saruul Enkhjargal, O. Lhagva-Ochir, Altangerel Purvee, et al.
Sexually Transmitted Infections (2025), pp. sextrans-056364
Closed Access
Stefano D’Anna, Romina Salpini, Elisabetta Degasperi, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Hepatocellular carcinoma: The virus or the liver?
Alkistis Papatheodoridi, George Papatheodoridis
Liver International (2022) Vol. 43, Iss. S1, pp. 22-30
Closed Access | Times Cited: 16
Alkistis Papatheodoridi, George Papatheodoridis
Liver International (2022) Vol. 43, Iss. S1, pp. 22-30
Closed Access | Times Cited: 16
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting
Toni Herta, Anna Joachim‐Richter, David Petroff, et al.
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 2
Toni Herta, Anna Joachim‐Richter, David Petroff, et al.
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 2
Natural history of untreated HDV patients: Always a progressive disease?
Habiba Kamal, Soo Aleman
Liver International (2022) Vol. 43, Iss. S1, pp. 5-21
Open Access | Times Cited: 10
Habiba Kamal, Soo Aleman
Liver International (2022) Vol. 43, Iss. S1, pp. 5-21
Open Access | Times Cited: 10
Advancing research, awareness, screening, and linkage to care to eliminate HDV in the U.S.
Megan Glynn, Chari Cohen, Robert G. Gish, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 4
Megan Glynn, Chari Cohen, Robert G. Gish, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 4
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication
Romina Salpini, Lorenzo Piermatteo, Giulia Torre, et al.
International Journal of Infectious Diseases (2023) Vol. 138, pp. 1-9
Open Access | Times Cited: 4
Romina Salpini, Lorenzo Piermatteo, Giulia Torre, et al.
International Journal of Infectious Diseases (2023) Vol. 138, pp. 1-9
Open Access | Times Cited: 4
Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 12, pp. e715-e732
Closed Access | Times Cited: 4
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 12, pp. e715-e732
Closed Access | Times Cited: 4
Progression of liver disease and associated risk of hepatocellular carcinoma
Edoardo Poli, Eléonora De Martin
Hepatoma Research (2024)
Open Access | Times Cited: 1
Edoardo Poli, Eléonora De Martin
Hepatoma Research (2024)
Open Access | Times Cited: 1
Investigating the Genetic Diversity of Hepatitis Delta Virus in Hepatocellular Carcinoma (HCC): Impact on Viral Evolution and Oncogenesis in HCC
Horng‐Heng Juang, Chao‐Wei Hsu, Kang‐Shuo Chang, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 817-817
Open Access | Times Cited: 1
Horng‐Heng Juang, Chao‐Wei Hsu, Kang‐Shuo Chang, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 817-817
Open Access | Times Cited: 1
Disease modifiers and novel markers in HBV-related HCC
Lung‐Yi Mak
Journal of Liver Cancer (2024) Vol. 24, Iss. 2, pp. 145-154
Open Access | Times Cited: 1
Lung‐Yi Mak
Journal of Liver Cancer (2024) Vol. 24, Iss. 2, pp. 145-154
Open Access | Times Cited: 1
The Changing Face of Hepatitis Delta Virus Associated Hepatocellular Carcinoma
Mariana Cardoso, Mariana Verdelho Machado
Cancers (2024) Vol. 16, Iss. 22, pp. 3723-3723
Open Access | Times Cited: 1
Mariana Cardoso, Mariana Verdelho Machado
Cancers (2024) Vol. 16, Iss. 22, pp. 3723-3723
Open Access | Times Cited: 1
Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal
Adrià Ramírez Mena, Ndèye Fatou Ngom, Judicaël Tine, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1614-1614
Open Access | Times Cited: 7
Adrià Ramírez Mena, Ndèye Fatou Ngom, Judicaël Tine, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1614-1614
Open Access | Times Cited: 7
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis
Romina Salpini, Stefano D′Anna, Lorenzo Piermatteo, et al.
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 12, pp. 1038-1047
Closed Access | Times Cited: 7
Romina Salpini, Stefano D′Anna, Lorenzo Piermatteo, et al.
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 12, pp. 1038-1047
Closed Access | Times Cited: 7
